Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo
The endogenous protein antizyme inhibitor (AZI) is a potential oncogene which promotes cell growth by both inhibiting antizyme (AZ) activity and releasing ornithine decarboxylase (ODC) from AZ-mediated degradation. High levels of ODC and polyamines are associated with numerous types of neoplastic tr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/5081/1/Olsen-2012-Knockdown_of_antizym.pdf |